RT Journal Article
SR Electronic
T1 Clinical and laboratory characteristics in outpatient diagnosis of COVID-19 in healthcare professionals in Rio de Janeiro, Brazil
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.22.20217851
DO 10.1101/2020.10.22.20217851
A1 Porto, Luís Cristóvão
A1 da Costa, Claudia Henrique
A1 Nunes, Alessandra Sant’Anna
A1 Bouzas, Isabel
A1 Ferreira, Tiago C.
A1 Porto, Vinicius M.
A1 Secco, Danielle A.
A1 Vilas Boas, Sandra P. C.
A1 Faria, Anamelia C.
A1 Marins, Rosangela A. G.
A1 Duarte, Cíntia A.
A1 Bittencourt, Elizabeth P.
A1 Loureiro, Anderson V.
A1 Santos, Angela Maria G.
A1 Souza, Vania Maria A.
A1 Silva, Fernanda H.
A1 Lopes, Maria Cristina
A1 Castro, Marcelle V.
A1 Silva, Areta D.
A1 Vasconcelos, Flavia M.
A1 Moreira, Diego S.
A1 Motta, Juliana P.
A1 Lima, Cristiano V.
A1 Menezes, Raphaela S.
A1 Brazão, Nathalia B. V.
A1 Nogueira, Jeane S.
A1 Villela Silva, Ana Paula
A1 Brito, Ingrid A.A.
A1 Costa, Scarlathe B.
A1 Lemes, Roberta Mariana R.
A1 dePaula, Jessica Isis O.
A1 Bongionanni, Giovanna L.
A1 Bezerra, Ohana C. L.
A1 Andrade-Neto, Valter V.
A1 Morette, Leonardo
A1 Barbosa, Rafael S.
A1 Sanches, Jose Afonso L.
A1 Melo, Pedro L.
A1 Freire, Sergio M.
A1 Souza, Romulo
A1 Gomes, Laiz
A1 Felizardo, Denize P.
A1 Rodrigues, Alexsandre V.
A1 Franco, Priscila A.
A1 Miranda, Renata
A1 Rufino, Rogerio
YR 2020
UL http://medrxiv.org/content/early/2020/10/26/2020.10.22.20217851.abstract
AB Aims This study aimed to identify the symptoms associated with early stage SARS-CoV-2 (COVID-19) infections in healthcare professionals (HCP) using both clinical and laboratory data.Methods A total of 1,297 patients, admitted between March 18 and April 8, 2020, were stratified according to their risk of developing COVID-19 using their responses to a questionnaire designed to evaluate symptoms and risk conditions.Results Anosmia/hyposmia (p <0.0001), fever (p<0.0001), body pain (p<0.0001), and chills (p=0.001) were all independent predictors for COVID-19, with a 72% estimated probability for detecting COVID-19 in nasopharyngeal swab samples. Leukopenia, relative monocytosis, decreased eosinophil values, CRP, and platelets were also shown to be significant independent predictors for COVID-19.Conclusions The significant clinical features for COVID-19 were identified as anosmia, fever, chills, and body pain. Elevated CRP, leukocytes under 5,400 x 109/L, and relative monocytosis (>9%) were common among patients with a confirmed COVID-19 diagnosis. These variables may help, in the absence of RT-PCR tests, to identify possible COVID-19 infections during pandemic outbreaks.Summary From March 19 to April 8 2020, 1,297 patients attended the Polyclinic Piquet Carneiro for COVID-19 detection. Healthcare professional data was analyzed, significant clinical features were anosmia, fever, chills and body pain. Elevated CRP, leukopenia and monocytosis were common in COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementRio de Janeiro Research Support Agency (FAPERJ), National Council Research (CNPq). The Laboratory of Histocompatibility and Cryopreservation received a thermocycler and a -80C freezer from COVID-19 donation open account for Pedro Ernesto University Hospital. Rio de Janeiro Health Secretary provided nucleic acid extraction and RT-PCR kits.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Local and National Ethics Committee (CAAE: 30135320.0.0000.5259).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available upon request.